Elmaagacli A - Search Results

1

Longitudinal Outcome over Two Decades of Unrelated Allogeneic Stem Cell Transplantation for Relapsed/Refractory Acute Myeloid Leukemia: An ALWP/EBMT Analysis.

Nagler A, Ngoya M, Galimard JE, Labopin M, Bornhäuser M, Stelljes M, Finke J, Ganser A, Einsele H, Kröger N, Brecht A, Bethge W, Edinger M, Kulagin A, Passweg J, Blau IW, Elmaagacli A, Schäfer-Eckart K, Platzbecker U, Schroeder T, Bunjes D, Tischer J, Martin S, Spyridonidis A, Giebel S, Savani B, Mohty M. Nagler A, et al. Among authors: elmaagacli a. Clin Cancer Res. 2022 Oct 3;28(19):4258-4266. doi: 10.1158/1078-0432.CCR-22-0809. Clin Cancer Res. 2022. PMID: 35670780

2

Prolonged administration of interferon-alpha in patients with chronic-phase Philadelphia chromosome-positive chronic myelogenous leukemia before allogeneic bone marrow transplantation may adversely affect transplant outcome.

Beelen DW, Graeven U, Elmaagacli AH, Niederle N, Kloke O, Opalka B, Schaefer UW. Beelen DW, et al. Among authors: elmaagacli ah. Blood. 1995 May 15;85(10):2981-90. Blood. 1995. PMID: 7742558 Free article.

3

Transplantation of filgrastim-mobilized peripheral blood stem cells from HLA-identical sibling or alternative family donors in patients with hematologic malignancies: a prospective comparison on clinical outcome, immune reconstitution, and hematopoietic chimerism.

Beelen DW, Ottinger HD, Elmaagacli A, Scheulen B, Basu O, Kremens B, Havers W, Grosse-Wilde H, Schaefer UW. Beelen DW, et al. Among authors: elmaagacli a. Blood. 1997 Dec 15;90(12):4725-35. Blood. 1997. PMID: 9389688 Free article.

4

A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.

Elmaagacli AH, Beelen DW, Schaefer UW. Elmaagacli AH, et al. Bone Marrow Transplant. 1997 Dec;20(12):1045-55. doi: 10.1038/sj.bmt.1701026. Bone Marrow Transplant. 1997. PMID: 9466277

5

Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.

Elmaagacli AH, Beelen DW, Kroll M, Trzensky S, Stein C, Schaefer UW. Elmaagacli AH, et al. Bone Marrow Transplant. 1998 Jan;21(2):159-66. doi: 10.1038/sj.bmt.1701056. Bone Marrow Transplant. 1998. PMID: 9489633

6

Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation.

Elmaagacli AH, Beelen DW, Trenn G, Schmidt O, Nahler M, Schaefer UW. Elmaagacli AH, et al. Bone Marrow Transplant. 1999 Apr;23(8):771-7. doi: 10.1038/sj.bmt.1701672. Bone Marrow Transplant. 1999. PMID: 10231138

7

The risk of residual molecular and cytogenetic disease in patients with Philadelphia-chromosome positive first chronic phase chronic myelogenous leukemia is reduced after transplantation of allogeneic peripheral blood stem cells compared with bone marrow.

Elmaagacli AH, Beelen DW, Opalka B, Seeber S, Schaefer UW. Elmaagacli AH, et al. Blood. 1999 Jul 15;94(2):384-9. Blood. 1999. PMID: 10397704 Free article.

8

The detection of wt-1 transcripts is not associated with an increased leukemic relapse rate in patients with acute leukemia after allogeneic bone marrow or peripheral blood stem cell transplantation.

Elmaagacli AH, Beelen DW, Trenschel R, Schaefer UW. Elmaagacli AH, et al. Bone Marrow Transplant. 2000 Jan;25(1):91-6. doi: 10.1038/sj.bmt.1702095. Bone Marrow Transplant. 2000. PMID: 10654021

9

Transplantation of highly purified HLA-identical sibling donor peripheral blood CD34+ cells without prophylactic post-transplant immunosuppression in adult patients with first chronic phase chronic myeloid leukemia: results of a phase II study.

Beelen DW, Peceny R, Elmaagacli A, Ottinger H, Kummer G, Opalka B, Seeber S, Schaefer UW. Beelen DW, et al. Among authors: elmaagacli a. Bone Marrow Transplant. 2000 Oct;26(8):823-9. doi: 10.1038/sj.bmt.1702635. Bone Marrow Transplant. 2000. PMID: 11081380 Clinical Trial.

10

A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.

Elmaagacli AH, Runkel K, Steckel N, Opalka B, Trenschel R, Seeber S, Schaefer UW, Beelen DW. Elmaagacli AH, et al. Bone Marrow Transplant. 2001 Apr;27(8):809-15. doi: 10.1038/sj.bmt.1703000. Bone Marrow Transplant. 2001. PMID: 11477437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page